Caricamento...
Phase I trials as valid therapeutic options for patients with cancer
For many years, oncology phase I trials have been referred to as ‘toxicity trials’ and have been believed to have low clinical utility other than that of establishing the adverse event profile of novel therapeutic agents. The traditional distinction of clinical trials into three phases has been chal...
Salvato in:
| Pubblicato in: | Nat Rev Clin Oncol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6868302/ https://ncbi.nlm.nih.gov/pubmed/31477881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41571-019-0262-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|